8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer)
Published . Updated .
8-K - Kiniksa Pharmaceuticals International filed an 8-K with the SEC on Oct 22 (a notice of a material company event).
Directly affected
- KNSA Kiniksa Pharmaceuticals International+0.5%
Named in this report.
Indirectly affected
- SPY SPDR S&P 500+1.6%
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond-1.8%
Long-term U.S. government bonds
- QQQ Invesco QQQ+2.3%
Large technology stocks
- GLD SPDR Gold Shares-3.3%
Gold can move with the broad market
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| KNSA | -2.71% | +3.05% | base | after close | after close | after close | after close |
| SPY | -0.09% | +0.66% | base | after close | after close | after close | after close |
| TLT | -2.07% | -1.97% | base | after close | after close | after close | after close |
| QQQ | +0.75% | +1.80% | base | after close | after close | after close | after close |
| GLD | +3.51% | +2.33% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-22 AccNo: 0001730430-26-000034 Size: 144 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Source: sec-edgar
Kiniksa Pharmaceuticals International (KNSA) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| GLD | three days earlier | +2.33% | final price |
| GLD | five days earlier | +3.51% | final price |
| Kiniksa Pharmaceuticals International (KNSA) | three days earlier | +3.05% | final price |
| Kiniksa Pharmaceuticals International (KNSA) | five days earlier | -2.71% | final price |
| QQQ | three days earlier | +1.80% | final price |
| QQQ | five days earlier | +0.75% | final price |
| SPY | three days earlier | +0.66% | final price |
| SPY | five days earlier | -0.09% | final price |
| TLT | three days earlier | -1.97% | final price |
| TLT | five days earlier | -2.07% | final price |
Who gains and who loses around Kiniksa Pharmaceuticals International (KNSA)
Companies tied to this story
- KNSA Kiniksa Pharmaceuticals International
In “8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer),” Kiniksa Pharmaceuticals International (KNSA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> KNSA
Kiniksa Pharmaceuticals International (KNSA)
On 22 Oct 2026, “8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer)” is the story that connects Kiniksa Pharmaceuticals International (KNSA) to this story.
What ties Kiniksa Pharmaceuticals International (KNSA) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> KNSA
Dates in the story, and the Kiniksa Pharmaceuticals International (KNSA) price range
KNSA traded between 73.42 and 84.06 across 20 sessions. The latest close on file is 79.68.
A simple score for Kiniksa Pharmaceuticals International (KNSA)
14 out of 100
“8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.